Exploring the causal connection: insights into diabetic nephropathy and gut microbiota from whole-genome sequencing databases.
探討因果關聯:來自全基因組測序數據庫的糖尿病腎病與腸道微生物群的見解。
Ren Fail 2024-08-02
Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota.
糖尿病腎病中的腸腎交互作用及針對腸道微生物的新型治療。
Acta Biochim Biophys Sin (Shanghai) 2023-02-11
The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease.
腸道菌群在糖尿病腎病發展和治療中的角色和機制。
Front Physiol 2023-05-30
Gut flora metagenomic analysis coupled with metabolic and deep immune profiling in chronic kidney disease.
慢性腎臟病中腸道菌群宏基因組分析結合代謝和深度免疫分析。
Nephrol Dial Transplant 2024-01-20
Longitudinal Pilot Evaluation of the Gut Microbiota Comparing Patients With and Without Chronic Kidney Disease.
慢性腎臟病患者與非患者腸道菌叢的縱向初步評估。
J Ren Nutr 2024-03-08
Evidence from mendelian randomization identifies several causal relationships between primary membranous nephropathy and gut microbiota.
Mendelian randomization 證據確認原發性膜性腎病與腸道菌叢之間的多個因果關係。
Ren Fail 2024-05-21
Association between the gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study.
腸道菌群與糖尿病腎病之間的關聯:一項雙樣本Mendelian randomization研究。
Ren Fail 2024-06-04
Causal relationship between 731 immune cells and the risk of diabetic nephropathy: a two‑sample bidirectional Mendelian randomization study.
731 免疫細胞與糖尿病腎病風險之因果關係:一項雙樣本雙向孟德爾隨機化研究。
Ren Fail 2024-08-02
Characteristics and function of the gut microbiota in patients with IgA nephropathy via metagenomic sequencing technology.
IgA腎病患者腸道微生物群的特徵及功能透過宏基因組測序技術。
Ren Fail 2024-08-23